Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RADfertility, formerly known as Reproductive Associates of Delaware, is a premier fertility center providing advanced reproductive medicine and surgical services. Established in 1995, the practice offers a comprehensive suite of services including in vitro fertilization (IVF), intrauterine insemination (IUI), egg freezing, and preimplantation genetic testing (PGT). In December 2022, the company was acquired by CCRM Fertility, integrating its clinical expertise with CCRM's global network and proprietary laboratory technologies. RADfertility operates three main locations in Delaware—Newark, Wilmington, and Dover—and maintains a robust clinical research program. The center actively participates in clinical trials for novel fertility treatments and diagnostic tools, contributing to advancements in reproductive endocrinology and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reproductive Associates of Delaware.